Afinitor and Zollinger-ellison syndrome - a phase IV clinical study of FDA data
Zollinger-ellison syndrome is reported only by a few people who take Afinitor.
The phase IV clinical study analyzes which people take Afinitor and have Zollinger-ellison syndrome. It is created by eHealthMe based on reports of 39,807 people who have side effects while taking Afinitor from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
39,807 people reported to have side effects when taking Afinitor.
Among them, 1 person (0.0%) has Zollinger-ellison syndrome.
What is Afinitor?
Afinitor has active ingredients of everolimus. It is often used in breast cancer metastatic. eHealthMe is studying from 39,878 Afinitor users for its effectiveness, alternative drugs and more.
What is Zollinger-ellison syndrome?
Zollinger-ellison syndrome (increased production of the hormone gastrin from a small tumour of pancreas) is found to be associated with 153 drugs and 169 conditions by eHealthMe.
Number of Afinitor and Zollinger-ellison syndrome reports submitted per year:
Gender of people who have Zollinger-ellison syndrome when taking Afinitor *:
- female: 0.0 %
- male: 100 %
Common drugs people take besides Afinitor *:
- Sandostatin: 1 person, 100.00%
Common side effects people have besides Zollinger-ellison syndrome *:
- Nausea And Vomiting: 1 person, 100.00%
- Nausea (feeling of having an urge to vomit): 1 person, 100.00%
- Constipation: 1 person, 100.00%
- Cholangitis (infection of the bile duct): 1 person, 100.00%
- Bedridden: 1 person, 100.00%
Common conditions people have *:
- Pancreatic Carcinoma (pancreatic cancer): 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Afinitor and have Zollinger-ellison syndrome?Check whether Zollinger-ellison syndrome is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Zollinger-ellison syndrome and when was it recovered:
Expand to all the drugs that have ingredients of everolimus:
Alternative drugs to, pros and cons of Afinitor:
- Afinitor (39,878 reports)
Common Afinitor side effects:
- Death: 5,716 reports
- Fatigue (feeling of tiredness): 4,180 reports
- Diarrhea: 3,836 reports
- Breathing difficulty: 2,776 reports
- Rashes (redness): 2,725 reports
- Pneumonia: 2,409 reports
Browse all side effects of Afinitor:a b c d e f g h i j k l m n o p q r s t u v w x y z
Zollinger-ellison syndrome treatments and more:
- Zollinger-ellison syndrome (1,123 reports)
COVID vaccines that are related to Zollinger-ellison syndrome:
- Zollinger-ellison syndrome in Moderna COVID Vaccine
- Zollinger-ellison syndrome in Pfizer BioNTech Covid Vaccine
- Zollinger-ellison syndrome in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Zollinger-ellison syndrome:
- Zollinger-ellison syndrome (153 drugs)
All the conditions that are associated with Zollinger-ellison syndrome:
- Zollinger-ellison syndrome (169 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on everolimus (the active ingredients of Afinitor) and Afinitor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Armodafinil and Allegra drug interaction - a second ago
- Temaz vs. Valerian - 6 seconds ago
- Triazolam and Neuroleptic Malignant Syndrome - 21 seconds ago
- Cromolyn Sodium and Psychotic Disorder - 27 seconds ago
- Back Injury and Enlarged Heart - 29 seconds ago
- Oxycodone Hydrochloride And Acetaminophen and Osteoarthritis - 38 seconds ago
- Tranexamic Acid and Naloxone drug interaction - 44 seconds ago
- Tymlos and Cardiac Disorder - 45 seconds ago
- Zometa and Adnexa Uteri Cyst - 46 seconds ago
- Augmentin '125' and Bronchopulmonary Dysplasia - 47 seconds ago